AptaBio Therapeutics Inc. (KOSDAQ:293780)
8,470.00
+150.00 (1.80%)
Apr 30, 2026, 3:30 PM KST
16.67% (1Y)
| Market Cap | 237.95B +23.6% |
| Revenue (ttm) | 3.70B +10.0% |
| Net Income | -16.35B |
| EPS | -607.00 |
| Shares Out | 28.09M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 210,310 |
| Average Volume | 132,294 |
| Open | 8,320.00 |
| Previous Close | 8,320.00 |
| Day's Range | 8,170.00 - 8,760.00 |
| 52-Week Range | 6,060.00 - 11,960.00 |
| Beta | 0.92 |
| RSI | 69.56 |
| Earnings Date | May 14, 2026 |